Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …

ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …

Background: The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors
and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown …

Background Angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin
receptor blockers (ARBs) are widely prescribed for primary hypertension (systolic blood …

Aims Renin–angiotensin–aldosterone system (RAAS) inhibitors are well established for the
reduction in cardiovascular morbidity, but their impact on all-cause mortality in hypertensive …

ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and
renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive …

Angiotensin converting enzyme inhibitors in hypertension: po... : Journal of Hypertension
Angiotensin converting enzyme inhibitors in hypertension: potential problems : Journal of …

In the treatment of most medical conditions, there are many choices. A critical question for
practicing clinicians is:“Are all drugs within a class interchangeable?” In the past decade, the …

When first introduced in 1981, angiotensin-converting enzyme (ACE) inhibitors were
indicated only for treatment of refractory hypertension. Since then, they have been shown to …

Angiotensin II not only is a vasoconstrictor, but it also affects cell growth and apoptosis,
inflammation, fibrosis, and coagulation. Blockade of the renin-angiotensin system, either …